Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Amiloride (MK-870) for Ion Transport Workflows
2026-09-20
Amiloride (MK-870) gives researchers a practical perturbation tool for ENaC-, PC2-, and uPAR-linked biology, from epithelial flux assays to uptake studies. Its most valuable emerging role is as a mechanistic control for testing whether ionic transport influences nanoliposome trafficking and antigen-presentation workflows.
-
Berberine, Evodiamine, and TRPV1 in GERD
2026-09-19
The reference study shows that berberine and evodiamine improve experimental gastroesophageal reflux disease by coordinating TAS2R38 and TRPV1 signaling with MAPK/NF-κB activity, epithelial barrier maintenance, and macrophage polarization. Its combination of animal modeling, bile acid-stressed human esophageal epithelial cells, receptor silencing, calcium assays, and RTX-based validation provides a useful framework for testing receptor-directed interventions in reflux inflammation.
-
HyperScript™ Reverse Transcriptase for Retina
2026-09-18
Discover how HyperScript™ Reverse Transcriptase can strengthen RNA to cDNA conversion when retinal transcriptomics involves structured, scarce, or long RNA templates. This article translates a gut–RPE/choroid study into practical assay-design decisions without overstating what the evidence proves.
-
Telatinib Workflow for Angiogenesis Assays
2026-09-18
Build a practical Telatinib workflow that connects VEGFR pathway inhibition with tumor-cell proliferation, invadopodia formation, and endothelial tube formation. The approach combines dose calibration, orthogonal phenotypes, and troubleshooting controls so BAY 57-9352 results are easier to interpret than a single viability readout.
-
Sulfo-NHS-Biotin for Phage Assay Workflows
2026-09-17
Sulfo-NHS-Biotin connects selective amine labeling with practical capture, enrichment, and cell-surface workflows. This guide shows how to use it as a protein labeling reagent and as a method-development component for phage-layer interferometry, while preserving controls for binding, lysis, and sample integrity.
-
Berberrubine chloride: Applied Research Workflows
2026-09-17
Berberrubine chloride supports mechanism-led workflows spanning inflammatory signaling, colorectal cancer research, NSCLC chemosensitivity, and urate biology. This guide translates published ARPE-19 findings into practical assay design, dosing, solubilization, controls, and troubleshooting strategies.
-
Caspase-3 Colorimetric Assay Kit: Practical Guide
2026-09-16
The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a lysate-based method for measuring DEVD-dependent caspase-3 activity through p-nitroaniline release. It is appropriate for comparative apoptosis studies and caspase activity measurement, but the colorimetric signal should not be interpreted as standalone proof of apoptosis or exclusive caspase-3 activity.
-
Phosbind Biotin LC: Practical Western Blot Guide
2026-09-16
Phosbind Biotin LC is a phosphate-binding reagent for sequence-independent detection of phosphorylated proteins on PVDF membranes. It is intended for Western Blot workflows using streptavidin-HRP and chemiluminescence, not aqueous-only protocols or long-term storage of prepared solutions.
-
Galectin-1–FIP200 Axis in Hepatic Steatosis
2026-09-15
A 2026 study identifies galectin-1 as an upstream inhibitor of hepatic autophagy that promotes steatosis, dyslipidemia, and insulin resistance through direct interaction with FIP200. By combining mouse gain-of-function models, proteomic profiling, binding analysis, structural mapping, and interaction-disrupting mutations, the work defines the Gal-1–FIP200 axis as a mechanistic target for metabolic liver disease research.
-
X-Gal Workflows for Reliable Blue-White Screening
2026-09-15
Turn X-Gal chemistry into a practical cloning decision point, from plate preparation and colony scoring to confirmation of recombinant inserts. This workflow also clarifies how lacZ-based screening complements, but does not replace, the RNA, imaging, and signaling assays used to study iRhom2-dependent olfactory biology.
-
Birinapant: A Functional Map of Cancer Apoptosis
2026-09-14
Birinapant (TL32711) provides a mechanistic way to probe IAP-controlled apoptosis alongside MDM1–p53 biology in colorectal cancer. This article translates its molecular pharmacology into assay and biomarker strategies while distinguishing established evidence from testable research hypotheses.
-
ONX-0914 (PR-957) Immunoproteasome Workflows
2026-09-14
ONX-0914 (PR-957) enables selective LMP7 inhibition for cytokine studies, autoimmune disease models, and mechanism-focused proteasome research. Its airway application requires special caution: genetic LMP7 loss can worsen rhinovirus-associated inflammation, making compartment, timing, and antiviral readouts essential.
-
In Vitro Metrics for Cancer Drug Responses
2026-09-13
Hannah Schwartz’s dissertation shows that relative viability and fractional viability measure different biological consequences of anticancer treatment rather than interchangeable versions of the same endpoint. The work provides a practical framework for separating proliferative arrest from cell killing, improving interpretation of preclinical drug-response experiments.
-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-09-12
This 2025 Cancer Letters review integrates tumor hypoxia, metabolic reprogramming, and immune-cell dysfunction into a dynamic model of immunosuppressive tumor-microenvironment evolution. Its main practical implication is that therapeutic and experimental strategies should assess oxygen limitation, nutrient competition, and immune phenotype together rather than treating them as isolated variables.
-
ECL Chemiluminescent Substrate Detection Kit
2026-09-12
The ECL Chemiluminescent Substrate Detection Kit uses horseradish peroxidase (HRP) chemiluminescence for sensitive immunoblotting on nitrocellulose and PVDF membranes. Product specifications report low-picogram protein detection, a 6 to 8 hour signal under optimized conditions, and 24-hour working-reagent stability.